Magnolia Regenerative Medicine Tirzepatide Review: $199/Month (2026)

Magnolia Regenerative Medicine charges $199.00 a month for compounded tirzepatide with B12, dosed at 2.5 mg weekly and billed every month. That figure is not on the product page. It appears at step 21 of a 22-screen intake, after the shipping address, and was read there on 1 September 2026.¹

The $179 you are shown, and the $199 you pay

The catalog advertises "Starting at $179" for tirzepatide with B12, and the arithmetic behind it is exact: the three-month plan costs $537.00, and $537 divided by three is $179. That plan holds you at the minimum dose and appears only on the continuing-patient branch. Answer "this would be my first time" and the menu changes to a titration plan running 2.5 to 5 to 7.5 mg, priced at $597.00 per three months — which is $199.00 a month, exactly what paying monthly costs. A new patient cannot reach the advertised entry price at all.

A third price pair, and a sitemap pointing at nothing

The GLP-1 landing page sells a differently-named product, "Tirzepatide with B-6", at "from $159/mo.", alongside semaglutide with B-6 at "from $109/mo." Neither figure appears in the catalog, on the product pages or in either intake. Then there is the domain problem. All 127 URLs in the sitemap point at magnoliaregenerative.com, which returns NXDOMAIN with no records of any kind, and the Terms' only cancellation channel is an address on that same dead domain. Mail to it cannot be delivered, so the one route the contract names for canceling does not exist.

Where it will treat you, and where it will not

Twenty-six jurisdictions are listed by name in the FAQ, the District of Columbia among them. Louisiana is not one of them, although both clinics are in Louisiana — Ville Platte and Lake Charles — and no in-clinic price of any kind is published on the site. Refunds are refused outright, including where the company itself ends the membership. Labs are billed separately at $89 or $189.

The brand-vs-compounded question

What is dispensed is compounded tirzepatide, not Zepbound. A compounded drug is prepared by a pharmacy, is not itself an FDA-approved finished product, and was not the formulation the pivotal trials enrolled patients on. Our guide to whether compounded tirzepatide is still legal in 2026 covers the regulatory position.

How the care model holds up

In its favor: a named legal entity, two physical clinic addresses, a working phone number and support address, a state list that is enumerated rather than asserted, and an intake that shows prepay plans as totals rather than only per-month equivalents. Against it: no compounding pharmacy is named, no clinician is named, no 503A or 503B designation appears anywhere, the advertised price is unreachable for the patient most likely to click it, and the paperwork routes you to a domain that no longer resolves.

Does the drug work? (Separate from the provider)

Judge the seller on price, disclosure and oversight, and judge the molecule on its own record. Tirzepatide's is strong — roughly 15% to 21% of body weight over 72 weeks in SURMOUNT-1², and ahead of semaglutide when the two were compared directly in SURMOUNT-5³ — but both trials used the branded drug at approved doses. Our tirzepatide evidence guide sets out what transfers and what does not.

The honest verdict

$199.00 a month is a fair price, and it is not the price the site advertises to the reader most likely to pay it. That gap, plus an anonymous pharmacy and a cancellation address that bounces, is what to weigh. MEDGm plays a similar trick with a $279 first month over a $399 standing rate, but it does name four pharmacy partners. NEUVÉ Health at $324 puts its whole ladder in the open with no intake at all, though it gives three incompatible answers about what the figure includes. The ranked best tirzepatide providers list places all three.